Strengthening Drug Price Accountability 

This bill would support improvements to the state’s Prescription Drug Affordability Board, to stop drug companies from unwarranted price increases on prescription drugs. Dozens of patients across the state testified in support of this bill and described the issues they face trying to afford their prescription drugs. The bill did not pass in the 2023 session, but the state budget directed the state Health Care Authority to study prescription drug services and report on the federal 340B drug pricing program to determine the best way to support lower prescription drug costs for nonprofit safety net hospitals and clinics.